X

pharmaceuticals

Infographic: Key highlights from Abbott Laboratories’ (ABT) Q3 2023 earnings results

Abbott Laboratories (NYSE: ABT) reported third quarter 2023 earnings results today. Net sales decreased 2.6% year-over-year to $10.1 billion. On an…

Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand…

Johnson & Johnson to report earnings on Oct 17. Here’s what to look for

After reporting better-than-expected quarterly earnings consistently for over a decade, healthcare behemoth Johnson & Johnson (NYSE: JNJ) is preparing to…

UnitedHealth earnings preview: Another beat in cards despite cost concerns

Over the years, UnitedHealth Group Incorporated (NYSE: UNH) has expanded steadily through diversification and acquisitions, all along creating value for…

What to look for when Walgreens Boots Alliance reports earnings on Oct. 12

Retail pharmacy chain Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is on the path to a transformation as it looks to…

Ocean Biomedical announces loan commitment of up to $10 million from largest stockholder

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers to develop and commercialize…

Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in…

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues.…

Earnings Summary: Here’s how CooperCompanies (COO) performed in Q3 2023

Medical device maker CooperCompanies (NYSE: COO) announced financial results for the third quarter of 2023, reporting an increase in revenues.…

Ocean Biomedical (OCEA) announces new patent for anti-fibrosis discovery

Ocean Biomedical, Inc. (NASDAQ: OCEA), a leading biopharma company that works to accelerate the development and commercialization of scientifically compelling…

MEDS Earnings: Highlights of Trxade Health’s Q2 2023 financial results

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter…

Cardinal Health Inc Q4 2023 Earnings Conference Call Insights

Key highlights from Cardinal Health Inc (CAH) Q4 2023 Earnings Concall Management Update: [00:02:00] CAH delivered record financial performance, including…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries…

Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results

Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted…

Illumina, Inc Q2 2023 Earnings Conference Call Insights

Key highlights from Illumina, Inc (ILMN) Q2 2023 Earnings Concall Management Update: [00:07:42] ILMN now expects to ship more than…

Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday provided an update on its broad range of programs in malaria, fibrosis, and…

Earnings Summary: Highlights of Illumina’s Q2 2023 results

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023. Second-quarter revenue came…

Earnings Summary: Highlights of Organon’s Q2 2023 results

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter…

Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights

Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim…

Earnings Summary: Charles River Laboratories reports Q2 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023.…

Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the…